Published in Brain Res on August 17, 2006
A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms. Eur J Pharmacol (2009) 1.06
Endogenous opiates and behavior: 2006. Peptides (2007) 0.92
Drug-sensitive reward in crayfish: an invertebrate model system for the study of SEEKING, reward, addiction, and withdrawal. Neurosci Biobehav Rev (2010) 0.84
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur J Pharmacol (2007) 0.78
Guarana provides additional stimulation over caffeine alone in the planarian model. PLoS One (2015) 0.76
d-Amphetamine stimulates unconditioned exploration/approach behaviors in crayfish: towards a conserved evolutionary function of ancestral drug reward. Pharmacol Biochem Behav (2011) 0.76
Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther (2004) 2.27
Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther (2009) 1.13
Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther (2002) 1.10
Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology (2009) 1.08
Quantitation of the contractile response mediated by two receptors: M2 and M3 muscarinic receptor-mediated contractions of human gastroesophageal smooth muscle. J Pharmacol Exp Ther (2009) 0.97
Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction. Am J Physiol Regul Integr Comp Physiol (2002) 0.97
Midazolam enhances the analgesic properties of dexmedetomidine in the rat. Vet Anaesth Analg (2010) 0.96
Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: an isobolographic analysis. Neuropeptides (2007) 0.94
Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther (2008) 0.92
A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J Pharmacol Exp Ther (2006) 0.92
Combination strategies for pain management. Expert Opin Pharmacother (2003) 0.91
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain Res Bull (2010) 0.90
The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J Pain (2010) 0.89
Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia. Pain (2007) 0.88
The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions. J Pharmacol Exp Ther (2008) 0.88
Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells. Life Sci (2011) 0.87
Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain. J Pharmacol Exp Ther (2002) 0.86
The dynamic relationship between mu and kappa opioid receptors in body temperature regulation. Life Sci (2005) 0.85
Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods (2005) 0.85
kappa-Opioid withdrawal in Planaria. Neurosci Lett (2003) 0.85
Fixed-dose combinations for emerging treatment of pain. Expert Opin Pharmacother (2012) 0.84
A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. Eur J Pharmacol (2008) 0.83
A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Methods (2004) 0.82
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res (2004) 0.81
Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. Eur J Pharmacol (2006) 0.81
Comparison of human and porcine gastric clasp and sling fiber contraction by M2 and M3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol (2010) 0.80
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain. Eur J Pharmacol (2011) 0.80
On the quantitation of an agonist with dual but opposing components of action: application to vascular endothelial relaxation. Eur J Pharmacol (2011) 0.80
Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats. Psychopharmacology (Berl) (2013) 0.79
Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice. J Pharmacol Exp Ther (2013) 0.79
Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology (2005) 0.78
Effects of drug combinations on smooth muscle cell proliferation: an isobolographic analysis. Eur J Pharmacol (2006) 0.78
Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy. Eur J Pharmacol (2006) 0.77
Diselenium, instead of disulfide, bonded analogs of conotoxins: novel synthesis and pharmacotherapeutic potential. Life Sci (2010) 0.77
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behav Pharmacol (2015) 0.77
Chemo fog: cancer chemotherapy-related cognitive impairment. Preface. Adv Exp Med Biol (2010) 0.77
Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. Life Sci (2005) 0.76
Combining opioid and adrenergic mechanisms for chronic pain. Postgrad Med (2014) 0.76
Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. Eur J Pharmacol (2004) 0.76
Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur J Pharmacol (2006) 0.76
Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition. Drug Alcohol Depend (2012) 0.75
Modified 'Joyce model' of opioid dependence/withdrawal. Eur J Pharmacol (2006) 0.75
Intracerebroventricular opioids for intractable pain. Br J Clin Pharmacol (2012) 0.75
Future directions. Adv Exp Med Biol (2010) 0.75
Protonation effect on drug affinity. Eur J Pharmacol (2004) 0.75
Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery. Eur J Pharmacol (2004) 0.75